Aptevo Therapeutics (APVO) Intangibles (2015 - 2019)
Aptevo Therapeutics (APVO) posted Intangibles of $4.4 million for Q4 2019, down 4.49% sequentially from $4.6 million in Q3 2019, and down 15.81% YoY from $5.2 million in Q4 2018.
Aptevo Therapeutics (APVO) Intangibles (2015 - 2019) Analysis & Trends
Aptevo Therapeutics has reported Intangibles for 5 years, with the latest figure at $4.4 million in Q4 2019.
- Quarterly Intangibles fell 15.81% year-over-year to $4.4 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $4.4 million (down 15.81% YoY) and the FY2019 annual result came in at $4.4 million, down 15.81% from the prior year.
- Intangibles eased to $4.4 million in Q4 2019 per APVO's latest filing, from $4.6 million in the prior quarter.
- Over five years, Intangibles peaked at $17.4 million in Q4 2015 and troughed at $4.4 million in Q4 2019.
- A 5-year average of $8.5 million and a median of $6.0 million in 2017 frame the typical range for Intangibles.
- The sharpest annual moves came in 2016 and 2017: Intangibles tumbled 60.38% in 2016, then fell 12.01% in 2017.
- Over 5 years, Intangibles stood at $17.4 million in 2015, then sank by 60.38% to $6.9 million in 2016, then retreated by 12.01% to $6.1 million in 2017, then retreated by 13.65% to $5.2 million in 2018, then retreated by 15.81% to $4.4 million in 2019.
- According to Business Quant data, Intangibles over the past three periods registered $4.4 million, $4.6 million, and $4.8 million for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 4.42 Mn |
| Sep 30, 2019 | 4.63 Mn |
| Jun 30, 2019 | 4.84 Mn |
| Mar 31, 2019 | 5.04 Mn |
| Dec 31, 2018 | 5.25 Mn |
| Sep 30, 2018 | 5.46 Mn |
| Jun 30, 2018 | 5.67 Mn |
| Mar 31, 2018 | 5.87 Mn |
| Dec 31, 2017 | 6.08 Mn |
| Sep 30, 2017 | 6.29 Mn |
| Jun 30, 2017 | 13.49 Mn |
| Mar 31, 2017 | 14.01 Mn |
| Dec 31, 2016 | 6.91 Mn |
| Sep 30, 2016 | 15.06 Mn |
| Jun 30, 2016 | 16.27 Mn |
| Dec 31, 2015 | 17.44 Mn |